---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-25-000007"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2025-02-06T23:59:59+00:00"
generated_at: "2026-05-27T01:28:47.776817+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Prestige Q3 FY2025 EPS $1.22 (+15% YoY); raises FY25 adjusted EPS outlook to ~$4.50

## Summary
- Q3 revenues $290.3M (+2.7% YoY); record quarterly sales and EPS.
- Diluted EPS $1.22 vs $1.06 prior year; net income $61.0M vs $53.0M.
- Raises FY25 adjusted EPS outlook to ~$4.50 from $4.40-$4.46; FCF ≥$240M reaffirmed.
- International OTC segment grew 11.3% (8.3% ex-FX); North American OTC +1.0%.
- Leverage reduced to 2.5x; repurchased 0.6M shares for ~$40.2M YTD.

## SEC filing metadata
- accession: 0001295947-25-000007
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2025-02-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000007/0001295947-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594725000007/pbh-20250206.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-25-000007
- JSON: https://secwatch.observer/filing/0001295947-25-000007.json
- Plain text: https://secwatch.observer/filing/0001295947-25-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.